Earnings

Elanco Animal Health Sees Q3 Adj EPS $0.19-$0.22 vs $0.20 Est; Sees Sales $1.195B-$1.220B vs $1.192B Est

Aug 5, 2026 · 06:29 AM ET· updated 1h ago

Elanco Animal Health (NYSE:ELAN) is looking for Q3 Adj EPS of $0.19-$0.22 vs $0.20 analyst estimate. sees sales of $1.195 billion-$1.220 billion vs $1.192 billion analyst estimate.

Why It Matters

Elanco (a pet and farm animal medicine company) says its third-quarter profits will be roughly what experts predicted, and its sales will be slightly higher. This tells us the company is on track and doing about as expected.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ELAN26.90

+1.29 (+5.06%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.